Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials (Q38908254)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials |
scientific article |
Statements
1 reference
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials (English)
1 reference
Zulfiqar A Bhutta
1 reference
Alessandra Anemona
1 reference
Audino Podda
1 reference
Elisa Marchetti
1 reference
Rana M Qasim Khan
1 reference
Maria Rosario Capeding
1 reference
Ashish Bavdekar
1 reference
Shabina Ariff
1 reference
Sajid B Soofi
1 reference
Muhammad A Habib
1 reference
Edison Alberto
1 reference
Sanjay Juvekar
1 reference
Rachid Marhaba
1 reference
Noshad Ali
1 reference
Nelia Malubay
1 reference
Anand Kawade
1 reference
Allan Saul
1 reference
Laura B Martin
1 reference
28 November 2013
1 reference
1 reference
14
1 reference
2
1 reference
119-129
1 reference
Identifiers
1 reference
1 reference